Photo of Lawrence Tanenbaum

Lawrence Tanenbaum

Print ProfilePrint Profile


    Dr. Tanenbaum is an active educator with interests in CT and MR, and an active speaker focusing on the application of advanced techniques in the clinical setting .  A senior member of the American Society of Neuroradiology, Dr. Tanenbaum is a past President of the Clinical Magnetic Resonance Imaging Society and Editor in Chief of the Journal “Vision” of the Clinical Magnetic Resonance Society, a member of the Roster of Distinguished Scientific Advisors of the RSNA as well as a number of panels and committees of the ACR including the Expert Panel on Neuroimaging and the CPI / Neuroradiology Expert Review Panel. Dr. Tanenbaum is a member of the editorial boards of several organizations and scientific journals.  Dr. Tanenbaum is an Associate Professor of Radiology and the Director of MRI, CT and Outpatient / Advanced Imaging Development at Mount Sinai School of Medicine in New York.


  • 2010 -
    Mentor Award-Third Prize
    American Society of Spine Radiology

  • 2009 -
    Certificate of Merit
    Radiological Society of North America

  • 2007 -
    The Communicator Award of Distinction
    GE Heathcare

  • 2004 -
    Telly Award Finalist
    GE Healthcare

  • 2004 -
    The Communicator Award of Distinction
    GE Healthcare


Verro P, Tanenbaum LN, Borden N, Eshkar N, Sen S. Clinical application of CT angiography in acute ischemic stroke. Clinical neurology and neurosurgery 2007 Feb; 109(2).

Tanenbaum LN. Clinical 3T MR imaging: mastering the challenges. Magnetic resonance imaging clinics of North America 2006 Feb; 14(1).

Tanenbaum LN. 3-T MR imaging: ready for clinical practice. AJNR. American journal of neuroradiology 2004 Oct; 25(9).

Tanenbaum LN. CT of acute stroke in the clinical setting. European radiology 2002 Jul; 12 Suppl 2.

Verro P, Tanenbaum LN, Borden NM, Sen S, Eshkar N. CT angiography in acute ischemic stroke: preliminary results. Stroke; a journal of cerebral circulation 2002 Jan; 33(1).

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Tanenbaum during 2014 and/or 2015. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.


  • Olea Medical Solutions Inc.

Scientific Advisory Board:

  • Vital Images, Inc.

Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose.

  • Bayer; GE HealthCare; Siemens; Vital Images, Inc.

Other Activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership.

  • Bayer HealthCare Pharmaceuticals / Onyx Pharmaceuticals Partnership

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central


Klingenstein Pavillion Floor MC Level
1176 Fifth Avenue
New York, NY 10029

Tel: 212-241-8333
Fax: 212-348-7403